CHEMICALLY-INDUCED DISORDERS
Clinical trials for CHEMICALLY-INDUCED DISORDERS explained in plain language.
Never miss a new study
Get alerted when new CHEMICALLY-INDUCED DISORDERS trials appear
Sign up with your email to follow new studies for CHEMICALLY-INDUCED DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test
Disease control Recruiting nowThis phase 2 trial tests whether semaglutide, a GLP-1 drug used for diabetes and weight loss, can help adults with opioid use disorder avoid using illicit opioids. Participants already receiving buprenorphine or methadone treatment will take weekly semaglutide or a placebo for 12…
Matched conditions: CHEMICALLY-INDUCED DISORDERS
Phase: PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Mindfulness may ease chronic pain and cut opioid dangers
Symptom relief Recruiting nowThis study tests two approaches—mindfulness training and patient-centered pain management visits—to help adults with chronic pain who take long-term opioids. The goal is to reduce pain, improve quality of life, and lower the risk of opioid misuse. About 300 participants will be f…
Matched conditions: CHEMICALLY-INDUCED DISORDERS
Phase: PHASE3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC